Literature DB >> 28420037

Does surgery or radiation provide the best overall survival in Ewing's sarcoma? A review of the National Cancer Data Base.

Benjamin J Miller1, Yubo Gao1, Kyle R Duchman1.   

Abstract

BACKGROUND AND OBJECTIVES: There is continuing debate regarding the ideal modality for local control of the primary tumor for patients with Ewing's sarcoma. The primary aim of this study is to investigate the impact of the method of local control on overall survival in patients with Ewing's sarcoma.
METHODS: The National Cancer Data Base was used to identify patients <40 years of age with high-grade Ewing's sarcoma of bone. A Kaplan-Meier survival analysis was performed at 2, 5, and 10 years. Factors with a level of significance of P < 0.1 at the 5-year time point were included in a multivariate Cox proportional hazards model.
RESULTS: Diminished 5-year survival was noted for patients with metastatic disease, local control with radiation alone, age ≥18 years, tumor size >8 cm, and male sex while controlling for tumor site. Surgery alone was consistently the method of local control that resulted in the highest overall survival.
CONCLUSIONS: Surgery alone resulted in the best overall survival for patients with Ewing's sarcoma of bone. The results of this investigation provide support to the approach of surgical resection with negative margins when possible.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ewing's sarcoma; local control; overall survival; radiation

Mesh:

Year:  2017        PMID: 28420037     DOI: 10.1002/jso.24652

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  15 in total

1.  Fifty years of bone tumors.

Authors:  Meredith K Bartelstein; Patrick J Boland
Journal:  J Surg Oncol       Date:  2022-10       Impact factor: 2.885

2.  Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.

Authors:  Tyler Abarca; Yubo Gao; Varun Monga; Munir R Tanas; Mohammed M Milhem; Benjamin J Miller
Journal:  J Surg Oncol       Date:  2018-04-06       Impact factor: 3.454

3.  Indeterminate pulmonary nodules are not associated with worse overall survival in Ewing Sarcoma.

Authors:  K M Tsoi; D Tan; J Stevenson; S Evans; L M Jeys; R Botchu
Journal:  J Clin Orthop Trauma       Date:  2021-01-23

4.  CORR Insights®: Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.

Authors:  Steven Gitelis
Journal:  Clin Orthop Relat Res       Date:  2020-02       Impact factor: 4.755

5.  The Interval Between Preoperative Radiation and Surgery Is Not Associated with Overall Survival for Soft-tissue Sarcomas: An Analysis of the National Cancer Database.

Authors:  Christopher D Collier; Chang-Yeon Kim; Raymond W Liu; Patrick J Getty
Journal:  Clin Orthop Relat Res       Date:  2021-03-01       Impact factor: 4.755

6.  Skull and Spinal Ewing's Sarcoma in Children: An Institutional Study.

Authors:  Suchanda Bhattacharjee; Shivanand Reddy Venkata; Megha S Uppin
Journal:  J Pediatr Neurosci       Date:  2018 Oct-Dec

7.  A nomogram to predict prognosis in Ewing sarcoma of bone.

Authors:  Qiang Zhou; Zong-Yi Wu; Zhong-Qin Lin
Journal:  J Bone Oncol       Date:  2019-02-12       Impact factor: 4.072

8.  Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery.

Authors:  S E Bosma; C Lancia; A J Rueten-Budde; A Ranft; H Gelderblom; M Fiocco; M A J van de Sande; P D S Dijkstra; U Dirksen
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

9.  Limb saving surgery for Ewing's sarcoma of the distal tibia: a case report.

Authors:  Naoki Mizoshiri; Toshiharu Shirai; Ryu Terauchi; Shinji Tsuchida; Yuki Mori; Yusei Katsuyama; Daichi Hayashi; Yoshinobu Oka; Toshikazu Kubo
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

10.  Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92.

Authors:  Jeremy Whelan; Allan Hackshaw; Anne McTiernan; Robert Grimer; David Spooner; Jessica Bate; Andreas Ranft; Michael Paulussen; Herbert Juergens; Alan Craft; Ian Lewis
Journal:  Clin Sarcoma Res       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.